A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer

Abstract

BackgroundColorectal cancer (CRC) ranks third among the estimated cancer cases and cancer related mortalities in the Western world. Early detection and efficient therapy of CRC remains a major health challenge. Therefore, there is a need to identify novel tumor markers for early diagnosis and treatment of CRC.MethodsA-kinase anchor protein 4 (AKAP4) gene and protein expression was monitored by quantitative polymerase chain reaction (qPCR), reverse transcription (RT)-PCR and Western blotting in normal colon tissue lysate, normal colon epithelial cells and in colon cancer cell lines viz., Caco-2, COLO205, COLO320DM, HCT-15, HCT116, HT-29, SW480, and SW620. The effect of AKAP4 on cellular growth, migration and invasion abilities was studied using gene silencing approach. The role of AKAP4 in various pathways involved in cell cycle, apoptosis, senescence was investigated in in vitro and in human xenograft mouse model.ResultsOur studies showed that AKAP4 gene and protein expression was expressed in all colon cancer cells while no expression was detectable in normal colon cells. Ablation of AKAP4 led to reduced cellular growth, migration, invasion and increased apoptosis and senescence of CRC cells in in vitro assays and tumor growth in human xenograft mouse. Human colon xenograft studies showed a significant decrease in the levels of cyclins B1, D and E and cyclin dependent kinases such as CDK1, CDK2, CDK4 and CDK6. Interestingly, an up-regulation in the levels of p16 and p21 was also observed. Besides, an increase in the levels of pro-apoptotic molecules AIF, APAF1, BAD, BID, BAK, BAX, PARP1, NOXA, PUMA and cyt-C and Caspase 3, 7, 8 and 9 was also found in cancer cells as well as in xenograft tissue sections. However, anti-apoptotic molecules BCL2, Bcl-xL, cIAP2, XIAP, Axin2 and Survivin were down regulated in these samples. Our data also revealed elevated expression of epithelial marker E-cadherin and down regulation of EMT markers N-cadherin, P-cadherin, SLUG, α-SMA, SNAIL, TWIST and Vimentin. Further ablation of AKAP4 resulted in the down regulation of invasion molecules matrix metalloproteinase MMP2, MMP3 and MMP9.ConclusionAKAP4 appears to be a novel CRC-associated antigen with a potential for developing as a new clinical therapeutic target.Electronic supplementary materialThe online version of this article (doi:10.1186/s13046-015-0258-y) contains supplementary material, which is available to authorized users.

Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer

“…The down-regulation of the other apoptosis suppressor proteins (BCL-XL and MCL-1) in PCa cells treated with the combination of both drugs compared to either of the drugs alone further indicates the synergism of curcumin and docetaxel in inducing apoptosis via NF-κB signaling pathway (Figure 5A and 5B) (34). On the other hand, the up-regulation of the pro-apoptotic markers (BAK and BID) (35) in PCa cells treated with both drugs supports the synergistic effect of curcumin and docetaxel in inducing apoptosis. Moreover, our results demonstrate that the docetaxel-mediated apoptosis of both DU145 and PC3 are independent of pro-apoptotic caspases.…”

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

“…The effect of miR551b on cellular motility was analyzed by carrying out cell migration and invasion assay as described earlier (Jagadish et al, 2015). In brief, for migration assay, miR551b transfected MDA-MB-231 and MCF10A cells (1 3 10 5 cells) were seeded on the upper chamber of the Boyden chambers trans-well inserts (BD Biosciences, Bedford, MA, USA).…”

Down-regulation of TSGA10, AURKC, OIP5 and AKAP4 genes by Lactobacillus rhamnosus GG and Lactobacillus crispatus SJ-3C-US supernatants in HeLa cell line

“…In fact, it is a scaffold protein which is needed for effective sperm motility [21]. It has been recognized as a CTA in a variety of cancers, including breast, colorectal and cervical cancers [22][23][24].…”